Aging

Figure 2. Scatterplots of DNAmFitAge versus age separated by sex.
DNAmFitAge: Biological Age Indicator Incorporating Physical Fitness
Jun 7, 20234 min read
“We expect DNAmFitAge will be a useful biomarker for quantifying fitness benefits at an epigenetic level and can be used to evaluate exercise-based interventions.” Listen to an audio version of this press release BUFFALO, NY- June 7, 2023 – A…
Stress granules sequester Alzheimer’s disease-associated gene transcripts and regulate disease-related neuronal proteostasis
Stress Granules Control Alzheimer’s Gene Transcripts and Neuronal Proteostasis
Jun 1, 20233 min read
“Determining the mechanism underlying RNA sequestration in [stress granules] […] could represent a key goal in the discovery and development of suitable [Alzheimer’s disease] biomarkers and therapies.” BUFFALO, NY- June 1, 2023 – A new research paper was published on…
Figure 2. Univariate associations of minor alleles of four SNPs from the MLXIPL gene with AD and CHD in two samples drawn from US cohorts (A) and UK biobank (B).
External Factors Shape Genetic Predisposition to Lipids, Alzheimer’s and Heart Disease in MLXIPL Gene
May 24, 20234 min read
“Recent findings suggest that neurodegenerative and cardiovascular diseases may have overlapping etiologies […]” Listen to an audio version of this press release BUFFALO, NY- May 24, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as…

VIEW MORE AGING ARTICLES


ONCOTARGET

Figure 1: Canonical Src regulation involves the transition from an inactive closed state to an active open form.
Targeting the Src N-Terminal Regulatory Element in Cancer
Jun 9, 20233 min read
“[…] Src is a recognized oncotarget.” BUFFALO, NY- June 9, 2023 – A new research perspective was published in Oncotarget’s Volume 14 on May 19, 2023, entitled, “Targeting the Src N-terminal regulatory element in cancer.” The signaling pathways displayed by…
Figure 1: Response to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy.
Value of Chemotherapy Post Immunotherapy in Stage IV Non-Small Cell Lung Cancer
Jun 7, 20233 min read
“[…] large multicenter prospective randomized trials are needed to provide the clinical evidence for the use of [chemotherapy] in second line and third-line post [immunotherapy] failure.” Listen to an audio version of this press release BUFFALO, NY- June 7, 2023…
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression
BORIS Gene Mutation and Expression: Link to Breast Cancer Progression
Jun 5, 20233 min read
“The current study analyzed the correlation between BORIS mutations and the expression of the protein in breast cancer cases.” Listen to an audio version of this press release BUFFALO, NY- June 5, 2023 – A new research paper was published…

VIEW MORE ONCOTARGET ARTICLES ➜


ONCOSCIENCE

oncoscience
UPR-Induced Ovarian Cancer Cell Fusion: A Mechanism Favoring Drug Resistance?
May 26, 20233 min read
“UPR [unfolded protein response] modulation in combination with conventional chemotherapeutic drug treatments of ovarian cancer patients could represent an interesting therapeutic strategy […]” Listen to an audio version of this press release BUFFALO, NY- May 26, 2023 – A new…
oncoscience
ATAD3A: A Molecular Determinant Favoring Head and Neck Cancer Development
Apr 28, 20233 min read
“[…] developing targeted therapies that specifically inhibit ATAD3A in cancer cells while sparing normal cells will be a challenging but critical task.” Listen to an audio version of this press release BUFFALO, NY- April 28, 2023 – A new research…
Figure 1: Schematic workflow of the experimental procedure.
New Method of Clustering Colorectal Cancer Patients Using DPE Sequencing
Apr 7, 20233 min read
“[…] DPE analysis may have an important role in improving the diagnosis and management of CRC.” Listen to an audio version of this press release BUFFALO, NY- April 7, 2023 – A new editorial paper was published in Oncoscience (Volume…

VIEW MORE ONCOSCIENCE ARTICLES


GENES & CANCER

VCP is an essential gene for KRAS-mutant PDAC.
Genes & Cancer | VCP/p97 as a Therapeutic Target in KRAS-Mutant Pancreatic Cancer
Mar 24, 20233 min read
“In summary, our goal was to identify additional therapeutic targets for KRAS-driven PDAC.” Listen to an audio version of this press release BUFFALO, NY- March 24, 2023 – A new research paper was published in Genes & Cancer on March…
Genes & Cancer header
Genes & Cancer | Severe Herpesvirus Infection Beats Adult T-cell Leukemia/Lymphoma
Feb 24, 20234 min read
“Although contracting herpes simplex or herpes zoster is unpleasant, the mechanism by which these herpesvirus infections can produce a therapeutic effect […]” Listen to an audio version of this press release BUFFALO, NY- February 24, 2023 – A new editorial…
Figure 4: Signaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells.
Genes & Cancer | CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens
Feb 10, 20233 min read
PRESS RELEASE: A new review was published in Genes & Cancer on February 1, 2023, entitled, “CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.” Listen to an audio version of this press release BUFFALO, NY- February…

VIEW MORE GENES & CANCER ARTICLES


NEWS

SSP Annual Meeting 2023
Impact Journals at SSP 45th Annual Meeting
May 17, 20232 min read
Impact Journals is proud to participate at the Society for Scholarly Publishing (SSP) 45th Annual Meeting, which convenes May 31–June 2, 2023, in Portland, Oregon. Listen to an audio version of this press release BUFFALO, NY-May 17, 2023 – Impact…
Impact Journals is proud to participate at the American Association for Cancer Research (AACR) Annual Meeting 2023, which convenes April 14-19 in Orlando, Florida.
Impact Journals at AACR Annual Meeting 2023
Apr 4, 20232 min read
Impact Journals is proud to participate at the American Association for Cancer Research (AACR) Annual Meeting 2023, which convenes April 14-19 in Orlando, Florida. Listen to an audio version of this press release BUFFALO, NY-April 4, 2023 – Impact Journals…
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. This fundraiser is hosted by Roswell Park Comprehensive Cancer Center in Buffalo, New York.
Impact Journals Sponsors 2022 Ride for Roswell
Jun 14, 20224 min read
Impact Journals is sponsoring Team Open Access on June 25, 2022, in the annual cycling event to end cancer: The Ride for Roswell. Listen to an audio version of this press release BUFFALO, NY- June 14, 2022 – The Ride…

VIEW MORE NEWS